Deferring Agency at End-of-Life: The Role of Information and Advance Directives

How to cite

Hong, Nianyi; Handel, Ben; Root, Allyson; Yip, Michelle. 2019. "Deferring Agency at End-of-Life: The Role of Information and Advance Directives." AEA RCT Registry. AEARCTR-0004212. https://doi.org/10.1257/rct.4212-2.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Nianyi Hong* , Ben Handel , Allyson Root , Michelle Yip

* Primary investigator

Registry ID
AEARCTR-0004212
DOI
https://doi.org/10.1257/rct.4212-2.0
First registered
Last updated
Status
Completed
Trial dates
2019-05-01 – 2021-04-30
Countries
United States of America ()
JEL codes
I12 Health Behavior
Registry record
http://www.socialscienceregistry.org/trials/4212

Abstract

We propose a pilot randomized evaluation of strategies to facilitate advance directive completion in the aged 55+ patient population of our partner, Providence St. Joseph Health (PSJH). Despite the significant economic and personal implications of end-of-life health care decisions, many fail to document their wishes or to select a representative who can make medical decisions on their behalf. Descriptive evidence suggests that this results in sub-optimal outcomes including dissatisfaction and potentially unnecessary medical spending. However, it is not well understood why patients fail to engage in this apparently high-value planning. We propose a pilot randomized trial to study the effect of a targeted informational outreach to promote advance directive completion among 3,000 patients in 5 PSJH primary care clinics. This study is a follow-up and refinement of a JPAL-funded pilot study conducted during summer 2018 in two clinics at PSJH. Key outcomes will include advance directive completion rates, decisions made on advance directive forms, and eventually observed care decisions. We will also leverage surveys and granular data on patient health to better understand barriers to advance care planning and relate to underlying economic theory that explains behavior.

Experimental design

Individual patients in five clinics with upcoming appointments who do not have AD on file will be randomized into one of six treatment arms. These treatment arms are: (1) Pure Control, No Outreach; (2) Electronic Reminder Only; (3) Electronic Reminder + Paper Letter; (4) Electronic Reminder + Paper Letter + Traditional AD Form; (5) Electronic Reminder + Paper Letter + Simple AD Form; and (6) Electronic Reminder + Paper Letter + Simple AD Form + Info. The total number of patients aged 55+ having an appointment over a period of two months is, with no AD on file, is around 600 per clinic. This brings the total sample size to roughly 3,000.

Design details

Randomization method
Random number generator (Stata)
Randomization unit
Randomization will be done at the individual level
Clusters
5 PSJH primary care clinics; 6 separate arms of intervention of 500 individuals each
Observations
3,000 individuals across 5 clinics and 6 separate arms
Arms
500 individuals per arm; 6 separate arms for a total of 3,000 individuals
Primary outcomes
Uploads Advance Directive to EMR; Fraction Total Patients Uploaded Advance Directive to EMR (clinic level); Fraction Total Patients Completing healthcare proxy selection field (clinic level)
Secondary outcomes
Completes Surrogate Selection on AD; Completes Care Preferences on AD; Preference/Dis-preference for Life Support on AD (clinic and individual level); Preference/Dis-preference for Tube Feeding (clinic and individual level)

Cited by

No citation data available for this registration yet.

Keywords